NervGen Pharma Corp (NGEN) — Strategic Asset Allocation Index
NervGen Pharma Corp (NGEN) has a Strategic Asset Allocation Index of 0.0% as of March 2025. Strategic assets (PP&E of CA$- plus long-term investments of CA$0.00) total CA$0.00, measured against net assets of CA$1.39 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
NervGen Pharma Corp Strategic Asset Allocation Index (2020–2024)
This chart shows how NervGen Pharma Corp's Strategic Asset Allocation Index has evolved across 4 annual periods from 2020 to 2024. As of March 2025, the index stands at 0.0%, representing strategic assets of CA$0.00 against net assets of CA$1.39 Million CAD. Explore NGEN cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for NervGen Pharma Corp (2020–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for NervGen Pharma Corp from 2020 to 2024, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see NervGen Pharma Corp stock valuation.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.3% | CA$8.37K | CA$- | CA$8.37K | CA$2.58 Million | ▼ -1.9 pp |
| 2022 | 2.2% | CA$295.28K | CA$295.28K | CA$- | CA$13.46 Million | ▲ +2.2 pp |
| 2021 | 0.0% | CA$2.69K | CA$2.69K | CA$- | CA$16.82 Million | ▼ 0.0 pp |
| 2020 | 0.0% | CA$2.00K | CA$2.00K | CA$- | CA$5.92 Million | — |